CVE-2026-5781
An authorization vulnerability in MphRx's Minerva V3.6.0, specifically in the '/minerva/moUser/update' endpoint, could allow an authenticated user with user modification privileges to escalate their privileges by sending an HTTP request with a…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.23%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
An authorization vulnerability in MphRx's Minerva V3.6.0, specifically in the '/minerva/moUser/update' endpoint, could allow an authenticated user with user modification privileges to escalate their privileges by sending an HTTP request with a manipulated 'identifier' field. Successful exploitation of this vulnerability could allow an authenticated user to obtain administrator privileges. It is not possible to escalate privileges through the graphical user interface.
- CVSS 4.0
- 8.5 HIGHCVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/M
- EPSS
- 0.23% probability · 14th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-285
- Affected
- agilonhealth/minerva
- Source
- cve-coordination@incibe.es
References
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.